Publications de nos équipes - Mai 2011

Quelen C, Lippert E, Struski S, Demur C, Soler G, Prade N, Delabesse E, Broccardo C, Dastugue N, Mahon FX, Brousset P. Blood. 2011 May 26 ;117(21):5719-22.

 

 

Attarbaschi A, Mann G, Rosolen A, Williams D, Uyttebroeck A, Marky I, Lamant L, Horibe K, Wrobel G, Beishuizen A, Wössmann W, Reiter A, Mauguen A, Le Deley MC, Brugières L ; for the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) ALCL99 Trial. Blood. 2011 May 26 ;117(21):5616-5619.

 

 

Consensus recommendations for the uniform reporting of clinical trials : report of the International Myeloma Workshop Consensus Panel 1.
Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J ; International Myeloma Workshop Consensus Panel 1. Blood. 2011 May 5 ;117(18):4691-5.

 

 

Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia : a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities.
Perrot A, Luquet I, Pigneux A, Mugneret F, Delaunay J, Harousseau JL, Barin C, Cahn JY, Guardiola P, Himberlin C, Recher C, Vey N, Lioure B, Ojeda-Uribe M, Fegueux N, Berthou C, Randriamalala E, Béné MC, Ifrah N, Witz F. Blood. 2011 May 26. PMID : 21622650

 

 

Boué J, Blanpied C, Brousset P, Vergnolle N, Dietrich G. J Immunol. 2011 May 1 ;186(9):5078-84.

 

 

Neukomm LJ, Nicot AS, Kinchen JM, Almendinger J, Pinto SM, Zeng S, Doukoumetzidis K, Tronchère H, Payrastre B, Laporte JF, Hengartner MO. Development. 2011 May ;138(10):2003-14. 

 

 

Labialle S, Cavaillé J Bioessays. 2011 May 26. doi : 10.1002/bies.201100032. PMID : 21618561

 

 

Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, Marret H, Magaud L, Gillaizeau F, Chatellier G, Dargent D. J Clin Oncol. 2011 May 1 ;29(13):1686-91.

 

 

Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapies. Moreau P, Avet-Loiseau H, Harousseau JL, Attal M. J Clin Oncol. 2011 May 10 ;29(14):1898-906.

 

Dalvai M, Mondesert O, Bourdon JC, Ducommun B, Dozier C. Oncogene. 2011 May 12 ;30(19):2282-8.

 

 

Popa I, Therville N, Carpentier S, Levade T, Cuvillier O, Portoukalian J. PLoS One. 2011 ;6(5):e19974. Epub 2011 May 24. PMID : 21629700

 

 

Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Daraï E. Lancet Oncol. 2011 May ;12(5):469-76.

 

 

Record M, Subra C, Silvente-Poirot S, Poirot M. Biochem Pharmacol. 2011 May 15 ;81(10):1171-82.

 

 

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma : consensus statement.
Dimopoulos MA, Palumbo A, Attal M, Beksaç M, Davies FE, Delforge M, Einsele H, Hajek R, Harousseau JL, da Costa FL, Ludwig H, Mellqvist UH, Morgan GJ, San-Miguel JF, Zweegman S, Sonneveld P ; European Myeloma Network. Leukemia. 2011 May ;25(5):749-60.

 

Serum bilirubin and platelet count : a simple predictive model for survival in patients with refractory ascites treated by TIPS.
Bureau C, Métivier S, D’Amico M, Péron JM, Otal P, Pagan JC, Chabbert V, Chagneau-Derrode C, Procopet B, Rousseau H, Bosch J, Vinel JP. J Hepatol. 2011 May ;54(5):901-7.

 

Faguer S, De Sandre-Giovannoli A, Hemery M, Lévy N, Lamant L, Arveiler B, Rooryck C, Prouheze C, Vigouroux A, Chauveau D, Calvas P, Chassaing N. Eur J Med Genet. 2011 May-Jun ;54(3):310-3. 

 

 

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.
de Medina P, Paillasse MR, Ségala G, Khallouki F, Brillouet S, Dalenc F, Courbon F, Record M, Poirot M, Silvente-Poirot S. Chem Phys Lipids. 2011 May 27. PMID : 21641337

 

Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L, Nematalla H, Bellamy V, Bouaziz P, Peyrard S, Casteilla L, Bruneval P, Hagège AA, Agbulut O, Menasché P. Cardiovasc Res. 2011 May 12. PMID : 21565832

 

 

Hayder M, Poupot M, Baron M, Nigon D, Turrin CO, Caminade AM, Majoral JP, Eisenberg RA, Fournié JJ, Cantagrel A, Poupot R, Davignon JL. Sci Transl Med. 2011 May 4 ;3(81):81ra35. doi : 10.1126/scitranslmed.3002212. PMID : 21543721

 

 

Influence of amines on the size control of in situ synthesized ruthenium nanoparticles in imidazolium ionic liquids.
Salas G, Santini CC, Philippot K, Collière V, Chaudret B, Fenet B, Fazzini PF. Dalton Trans. 2011 May 7 ;40(17):4660-8.

 

Lassadi I, Bystricky K. Methods Mol Biol. 2011 ;745:499-522.

 

A dielectrophoretic continuous flow sorter using integrated microelectrodes coupled to a channel constriction.
Salomon S, Leichlé T, Nicu L. Electrophoresis. 2011 Jun ;32(12):1508-14. doi : 10.1002/elps.201000675. Epub 2011 May 11. PMID : 21563186

 

 

Ruthenium nanoparticles in ionic liquids : structural and stability effects of polar solutes.
Salas G, Podgoršek A, Campbell PS, Santini CC, Pádua AA, Costa Gomes MF, Philippot K, Chaudret B, Turmine M. Phys Chem Chem Phys. 2011 May 20. PMID : 21603700

 

Cibula D, Abu-Rustum NR, Benedetti-Panici P, Köhler C, Raspagliesi F, Querleu D, Morrow CP. Gynecol Oncol. 2011 May 16. PMID : 21592548

 

 

Lèguevaque P, Motton S, Courbon F, Ricard M, Berry I, Querleu D. World J Surg. 2011 May ;35(5):995-1001.

 

 

Martinez A, Pomel C, Mery E, Querleu D, Gladieff L, Ferron G. Gynecol Oncol. 2011 May 1 ;121(2):258-63

 

 

The THEMA study : a sociodemographic survey of hypercholesterolaemic individuals.
Fournier T, Bruckert E, Czernichow S, Paulmyer A, Poulain JP. Hum Nutr Diet. 2011 May 17. doi : 10.1111/j.1365-277X.2011.01168.x. PMID : 21585569

 

 

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer : the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO).
Lortholary A, Largillier R, Weber B, Gladieff L, Alexandre J, Durando X, Slama B, Dauba J, Paraiso D, Pujade-Lauraine E ; on behalf of the GINECO group, France. Ann Oncol. 2011 May 11. PMID : 21562072

 

 

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, Garber J, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly M, Isaacs C, Stoppa-Lyonnet D, Sinilnikova OM, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA ; GEMO Study Collaborators, Rookus MA, Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen J, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna H, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomassen M, Domchek S, Nathanson K, Caligo M, Jernström H, Liljegren A, Ehrencrona H, Karlsson P ; SWE-BRCA, Ganz PA, Olopade OI, Tomlinson G, Neuhausen S, Antoniou AC, Chenevix-Trench G, Rebbeck TR. Cancer Epidemiol Biomarkers Prev. 2011 May ;20(5):1032-8.

 

Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Martinez A, Pomel C, Mery E, Querleu D, Gladieff L, Ferron G. Gynecol Oncol. 2011 May 1 ;121(2):258-63.

 

The heterodimeric ecdysteroid receptor complex in the brown shrimp Crangon crangon : EcR and RXR isoform characteristics and sensitivity towards the marine pollutant tributyltin.
Verhaegen Y, Parmentier K, Swevers L, Renders E, Rougé P, De Coen W, Cooreman K, Smagghe G. Gen Comp Endocrinol. 2011 May 15 ;172(1):158-69.

Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow® assay ? Role of haematocrit and haemoglobin levels.
Voisin S, Bongard V, Tidjane MA, Lhermusier T, Carrié D, Sié P. Thromb Haemost. 2011 May 5 ;106(1). PMID : 21544318

 

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, Garber J, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly M, Isaacs C, Stoppa-Lyonnet D, Sinilnikova OM, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA ; GEMO Study Collaborators, Rookus MA, Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen J, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna H, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomassen M, Domchek S, Nathanson K, Caligo M, Jernström H, Liljegren A, Ehrencrona H, Karlsson P ; SWE-BRCA, Ganz PA, Olopade OI, Tomlinson G, Neuhausen S, Antoniou AC, Chenevix-Trench G, Rebbeck TR. Cancer Epidemiol Biomarkers Prev. 2011 May ;20(5):1032-8.

 

 

Firstline treatment and maintenance in newly diagnosed multiple myeloma patients.
Roussel M, Facon T, Moreau P, Harousseau JL, Attal M. Recent Results Cancer Res. 2011 ;183:189-206. Review.

 

Ballereau S, Levade T, Génisson Y, Andrieu-Abadie N. Anticancer Agents Med Chem. 2011 May . PMID : 21554198

 

 

Paillard C, Lutz P, Michel G, Leverger G, Dalle JH, Demeocq F, Kanold J. Bull Cancer. 2011 May 1 ;98(5):541-548.

 

 

Evaluation of a trainer phantom in the learning phase of sentinel lymph node identification in breast cancer.
Lèguevaque P, Motton S, Courbon F, Ricard M, Berry I, Querleu D. World J Surg. 2011 May ;35(5):995-1001.